Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Geron, Pharmexa cancer news

The European Patent Office's Technical Board of Appeal upheld a 2005 decision to narrow PHARMX's European Patent No.

Read the full 184 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE